The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Press release from PR Newswire

Levi & Korsinsky, LLP Announces Investigation of Medicis Pharmaceutical Corporation (MRX), FSI Internaltional Inc. (FSII) and Deltek, Inc. (PROJ)

Thursday, September 06, 2012

Levi & Korsinsky, LLP Announces Investigation of Medicis Pharmaceutical Corporation (MRX), FSI Internaltional Inc. (FSII) and Deltek, Inc. (PROJ)11:22 EDT Thursday, September 06, 2012NEW YORK, Sept. 6, 2012 /PRNewswire/ -- Levi & Korsinsky is investigating the Board of Directors of Medicis Pharmaceutical Corporation (NYSE: MRX) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Valeant Pharmaceuticals International, Inc. (NYSE: VRX) for $44 per share. At least one analyst set a price target for Medicis stock at $45.00 per share.(Logo:  http://photos.prnewswire.com/prnh/20120409/MM84375LOGO )Click here to learn more about the investigation: http://zlk.9nl.com/medicis-pharmaceutical-mrx, or call: 877-363-5972. There is no cost or obligation to you.Levi & Korsinsky is investigating the Board of Directors of FSI International, Inc (Nasdaq: FSII) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Tokyo Electron Ltd. for $6.20 per share. At least one analyst set a price target for FSI stock at $7.50 per share.Click here to learn more about the investigation: http://zlk.9nl.com/fsi-international-fsii, or call: 877-363-5972. There is no cost or obligation to you.Levi & Korsinsky is investigating the Board of Directors of Deltek, Inc. (NasdaqGS: PROJ) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Thoma Bravo LLC. for $13.00 per share. An institutional investor representing 100% of Deltek's Class A and 59.5% of the Company's common stock has agreed to tender its shares.Click here to learn more about the investigation: http://zlk.9nl.com/deltek-proj, or call: 877-363-5972. There is no cost or obligation to you.Levi & Korsinsky is a national firm with offices in New York and Washington D.C.  The firm has extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits.  For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.CONTACT:    Levi & Korsinsky, LLPJoseph Levi, Esq.Eduard Korsinsky, Esq.30 Broad Street - 24th Floor New York, NY 10004            Tel: (212) 363-7500Toll Free:  (877) 363-5972Fax: (212) 363-7171www.zlk.com SOURCE Levi & Korsinsky, LLP